Asiatic acid as a leading structure for derivatives combining sub-nanomolar cytotoxicity, high selectivity, and the ability to overcome drug resistance in human preclinical tumor models-Reference-Cited by-同舟云学术

Asiatic acid as a leading structure for derivatives combining sub-nanomolar cytotoxicity, high selectivity, and the ability to overcome drug resistance in human preclinical tumor models

Published:2023-03 Issue: Volume:250 Page:115189
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Kraft Oliver,Hartmann Anne-Kathrin,Brandt Sarah,Hoenke Sophie,Heise Niels V.,Csuk René^ORCID,Mueller Thomas

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference41 articles.

1. Ayurveda and natural products drug discovery;Patwardhan;Curr. Sci.,2004

2. Traditional Chinese medicine as a cancer treatment: modern perspectives of ancient but advanced science;Xiang;Cancer Med.,2019

3. Traditional Chinese medicine for cardiovascular disease: evidence and potential mechanisms;Hao;J. Am. Coll. Cardiol.,2017

4. From traditional Ayurvedic medicine to modern medicine: identification of therapeutic targets for suppression of inflammation and cancer;Aggarwal;Expert Opin. Ther. Targets,2006

5. Ayurveda and cancer;Roopesh;Pharmacogn. Res.,2010

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dehydroabietylamine-substituted trifluorobenzene sulfonamide rhodamine B hybrids as anticancer agents overcoming drug resistance;European Journal of Medicinal Chemistry;2024-10

2. Time-dependent proteomics and drug response in expanding cancer cells;Pharmacological Research;2024-06

3. Can Asiatic Acid from Centella asiatica Be a Potential Remedy in Cancer Therapy?—A Review;Cancers;2024-03-28

4. Combination of Betulinic Acid Fragments and Carbonic Anhydrase Inhibitors—A New Drug Targeting Approach;Pharmaceutics;2024-03-14

5. Machine Learning-Based Metabolic Pattern Recognition Predicts Mode of Action for Anti-Cancer Drug Candidates;2024-01-26